Georgia Tech undergraduates organized and hosted a cross-campus symposium showcasing the impact and breadth of undergraduate neuroscience research.

Using artificial intelligence, the team is developing an edible vaccine that could protect birds from bird flu and reduce its spread to livestock and humans.

Prausnitz is awarded the highest honor given to a Georgia Tech professor.

Georgia Tech research shows how misaligned biotech–pharma partnerships can delay or derail drug development.

Students, faculty, and researchers from Georgia Tech and Kennesaw State University gathered on April 8 for a joint workshop.

The honorary society dates to the early days of the United States and honors excellence and contributions that advance society.

Life’s first alphabet was likely small — but surprisingly powerful.

A Georgia Tech researcher and his students are using experimental composting to reduce campus food waste and support agriculture.

Engineers interested in creating artificial cells to deliver drugs to unhealthy parts of the body face a key challenge: for a cell-like system to move, change shape, or divide, it needs a way to generate force on command.

AI and machine learning provide new tools for scientists to think about drug discovery.

A team of researchers led by Ankur Singh has been awarded up to $6 million from DTRA of the U.S. Department of Defense to accelerate the development of MCMs against deadly biological threats that endanger public health, national security, and warfighters.

When Mason Chilmonczyk, M.S. ME 2017, Ph.D. ME 2020, arrived at Georgia Tech to pursue graduate degrees in mechanical engineering, his goal was to become a professor. Instead, an unexpected turn in his research led him to entrepreneurship.